MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-4167

  1. 238 Posts.
    lightbulb Created with Sketch. 518
    https://finance.yahoo.com/video/mesoblast-expands-compassionate-covid-19-161852176.html

    The interview by Dr. Fred Grossman (thanks @Yor ) helps people understand why our Stem Cell Technology will be the no.1 treatment for COVID ARDS and all other inflammatory diseases in the future.

    "And those cytokines, which are wreaking havoc and destroying lung tissue and destroying kidney and other organs, actually respond to that by releasing anti-inflammatory factors. That tames this inflammatory response, allowing healing."

    Its not only about survival outcomes of some drug like Remdesivir to treat COVID ARDS.

    These patients organs including heart, kidneys and lungs are badly damaged even if they survive COVID ARDS using a simple drug like Remdesivir, in other words these patients are still stuffed!

    Our Stem Cell Technology is regenerative and heals the damaged organs as part of the process in recovering from COVID ARDS or COVID Multisystem inflammatory syndrome in children (MIS-C) due to infusions of our commercial product remestemcel-L.

    IMO, the FDA now understand the regenerative benefit of our Stem Cells, these other drugs can help immediate survival outcomes but are just 'old world" technology doing only doing a very small portion of the job to heal patients with these terrible inflammatory diseases.

    Other more knowledgeable posters can talk to the science.

    IMO, the world does not yet understand the paradigm shift to regenerative medicine which Mesoblast is forging the way ahead.

    GLTAB
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.